Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

France recalls rare disease drug Tavneos after deaths in Japan

France's medicine safety agency announced Wednesday the drug, which is used to treat rare autoimmune diseases, would be withdrawn after it was linked to a series of death in Japan.

France recalls rare disease drug Tavneos after deaths in Japan

We haven't written up this one. Le Monde English has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at lemonde.fr →

More in Health & Medicine

Vector Production a Bottleneck for Gene Therapy Sector

More effective purification materials would make viral vector production more efficient, say researchers working on an affinity adsorbent-based method they claim can differentiate between full and…

  • Viral vector reliance causes bottleneck in gene therapy sector
  • Current purification tech can't distinguish full from empty AAV capsids
  • New adsorbents and AI platform accelerate purification and reduce costs

Cell Therapy Company Aims to Pioneer Analytics Automation

BlueRock says it’s helping advance the cell therapy industry by developing an automated system for analytical auditing. They say it’s among the few systems specifically designed for this application.

  • BlueRock Therapeutics develops automated auditing system for cell therapies.
  • System bridges gap between existing solutions and cell therapy requirements.
  • Collaboration with Hamilton Robotics aims to scale up commercial automation.

More from Wednesday 19 August →